3.455
Goodrx Holdings Inc (GDRX) 最新ニュース
GoodRx stock price target lowered to $4.25 from $5.25 at UBS - Investing.com Australia
Deutsche Bank Adjusts GoodRx Price Target to $6 From $8, Maintains Hold Rating - MarketScreener
GoodRx Holdings: Buy Rating Maintained Despite Short-term Adjustments - AInvest
GoodRx Holdings Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
GoodRx Holdings Inc. stock chart pattern explainedVolume Confirmed Setup with Entry Confidence - Newser
Using AI based signals to follow GoodRx Holdings Inc.AI-Based Reversal Point Prediction Signal - Newser
Earnings visualization tools for GoodRx Holdings Inc.Weekly Market Direction and Sector Summary - Newser
How to integrate GoodRx Holdings Inc. into portfolio analysis toolsShort-Term AI-Based Stock Price Forecast - Newser
How GoodRx Holdings Inc. stock performs during market volatilityWealth Accumulation Outlook for Safe Investors - Newser
Statistical indicators supporting GoodRx Holdings Inc.’s strengthWeekly Return Plan for Conservative Traders - Newser
GoodRx downgraded to Outperform from Strong Buy at Raymond James - TipRanks
GoodRx stock downgraded by Raymond James on guidance cut after Rite Aid closures - Investing.com South Africa
Raymond James Downgrades GoodRx Holdings Inc. (GDRX) to Outperform - StreetInsider
Transcript : GoodRx Holdings, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges By Investing.com - Investing.com South Africa
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges - Investing.com Canada
Morgan Stanley Cuts Price Target on GoodRx Holdings to $5 From $6, Keeps Equalweight Rating - MarketScreener
Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding - simplywall.st
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at Morgan Stanley - StreetInsider
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds By Investing.com - Investing.com Australia
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds - Investing.com India
Analysts Weigh In on GoodRx Holdings (GDRX) and Arcutis Biotherapeutics (ARQT) - AInvest
Forecasting GoodRx Holdings Inc. price range with options dataTechnical Chart Summary for Momentum Stocks - Newser
GoodRx Holdings Inc. (GDRX) PT Lowered to $3.75 at Goldman Sachs - StreetInsider
GoodRx (NASDAQ:GDRX) Hits New 1-Year Low After Earnings Miss - Defense World
GoodRx Holdings Inc (GDRX) Q2 2025 Earnings Call Highlights: Str - GuruFocus
GoodRx Reports Steady Q2 2025 Financial Results - TipRanks
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Lag Estimates - MSN
Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics - MSN
Goodrx stock hits 52-week low at $3.67 By Investing.com - Investing.com South Africa
Goodrx stock hits 52-week low at $3.67 - Investing.com
GoodRx Misses Forecasts But Sees Growth Ahead In 2025 - Finimize
GoodRx Misses Targets But Pharma Unit Powers Growth - Finimize
Decoding GoodRx Holdings Inc (GDRX): A Strategic SWOT Insight - GuruFocus
GoodRx Holdings, Inc. Q2 Profit Increases, But Misses Estimates - Nasdaq
GoodRx Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Judge refuses to let Meta and Google off the hook in GoodRx health data sharing lawsuit - Class Action Lawsuits
Digital healthcare firm GoodRx Q2 revenue misses estimates - MarketScreener
GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 1c - StreetInsider
GoodRx Q2 2025 Financial Results - TradingView
GoodRx Reports Second Quarter 2025 Results - Business Wire
What makes GoodRx Holdings Inc. stock price move sharplyRisk Balanced Picks for Safer Trading - Newser
What data driven models say about GoodRx Holdings Inc.’s futureAlgorithmic Prediction of Market Breakouts - Newser
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 40% Potential Upside and Market Positioning - DirectorsTalk Interviews
Earnings Chart Overlay Points to GoodRx Holdings Inc. UpsideWeekly Watchlist of High Movers Released - beatles.ru
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
How does GoodRx Holdings Inc. generate profit in a changing economyGet daily expert analysis on top stocks - Jammu Links News
What institutional investors are buying GoodRx Holdings Inc. stockStrong return on investment - Jammu Links News
What is GoodRx Holdings Inc. company’s growth strategyCapitalize on strong market momentum - Jammu Links News
When is GoodRx Holdings Inc. stock expected to show significant growthUnlock powerful market insights for success - Jammu Links News
Is GoodRx Holdings Inc. a growth stock or a value stockBuild a diversified portfolio for risk management - Jammu Links News
What are analysts’ price targets for GoodRx Holdings Inc. in the next 12 monthsMaximize returns with strategic stock selection - Jammu Links News
What catalysts could drive GoodRx Holdings Inc. stock higher in 2025Fastest return on investment - Jammu Links News
What is the risk reward ratio of investing in GoodRx Holdings Inc. stockBuild a diversified portfolio for stability - Jammu Links News
How strong is GoodRx Holdings Inc. company’s balance sheetCapital growth strategies that work - Jammu Links News
Does GoodRx Holdings Inc. stock perform well during market downturnsBuild wealth steadily with proven methods - Jammu Links News
What is the dividend policy of GoodRx Holdings Inc. stockPowerful market insights - Jammu Links News
GoodRx Holdings Inc. Stock Analysis and ForecastSkyrocketing profit margins - Jammu Links News
大文字化:
|
ボリューム (24 時間):